Amicus Therapeutics Crashed 54%, But Chardan Is Buying

By: via Benzinga
Amicus Therapeutics, Inc (NASDAQ: FOLD) shares have plunged 54 percent in the last three months, despite crossing the $18 mark on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.